secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001213900-26-023022
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CPHI subsidiary acquires patent for $6.93M via stock; issues 12.6M shares
-------------------------------------------------------------------------

- Hainan Helpson acquires patent for Prinsepia Utilis Esterol Sublingual Tablets from Xiaoyan Zhang.
- Transfer price of $6.93M paid as 12.6M restricted shares of CPHI at $0.55 per share.
- Patent granted 2018, expires 2038; transferor provides technical services.
- Shares issued under Regulation S exemption as offshore transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390026023022/0001213900-26-023022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390026023022/ea0279672-8k_china.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-023022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer